Location History:
- Sunshine, AU (2013)
- Parkville, AU (2015)
- Hoppers Crossing, AU (2016)
- San Mateo, CA (US) (2018)
Company Filing History:
Years Active: 2013-2018
Title: **Brent Steven McKenzie: Innovating Neurological Treatments**
Introduction
Brent Steven McKenzie is a remarkable inventor based in Hoppers Crossing, Australia, with a significant contribution to the field of medicine through his innovative patents. With a total of five patents to his name, McKenzie focuses primarily on developing treatments for neurological inflammatory disorders, showcasing his expertise and dedication to improving patient outcomes.
Latest Patents
Among McKenzie’s latest inventions, one of his notable patents addresses the use of Factor XII inhibitors for treating neurological inflammatory disorders, including multiple sclerosis. This application outlines methods of administering Factor XII inhibitors to prevent, treat, or ameliorate the effects of such neuroinflammatory diseases. Additionally, he has developed agents and pharmaceutical compositions that inhibit FXII activity, marking a significant advancement in therapeutic options available for practitioners.
Another significant patent directed towards the treatment of inflammatory neurodegenerative conditions of the central nervous system introduces a method involving G-CSF or G-CSFR inhibiting agents. These include specific antibodies or molecules targeted to the nucleic acid encoding G-CSF, offering innovative approaches to combat these debilitating conditions.
Career Highlights
Brent McKenzie has an impressive career, working with notable organizations dedicated to medical research and development. He has contributed his expertise at CSL Limited, a global biotechnology leader, and the Ludwig Institute for Cancer Research Limited, an institution recognized for its extensive cancer research efforts. His work reflects a commitment to innovative medical solutions that address critical health issues.
Collaborations
In his journey as an inventor, McKenzie has collaborated with esteemed professionals in the field, notably his coworkers Eugene Maraskovsky and Peter Frederick Curwen. These collaborations have likely enhanced his research and innovation processes, contributing to the advancement of his patents and the impact of his work on treating neurological conditions.
Conclusion
In summary, Brent Steven McKenzie stands out as a dedicated inventor whose work has the potential to transform treatments for neurological inflammatory disorders. Through his patents and collaborations, he continues to push the boundaries of medical innovation, ultimately striving to improve the quality of life for those affected by such challenging conditions. His contributions are an inspiring testament to the impactful role of inventors in the realm of healthcare.